FDA Approves New Insomnia Drug
Key points
- The Food and Drug Administration on Wednesday approved a new drug for people with insomnia.
- The agency approved the sale of Lunesta, made by the pharmaceutical company Sepracor, for both chronic and occasional insomnia, a problem for millions of people.
- Lunesta was approved after clinical trials lasting more than a year showed it remained effective even when taker over time.
- The drug, taken as a pill, is non-narcotic, the company reported, and helps people remain asleep all night, not just to fall asleep.
The Food and Drug Administration on Wednesday approved a new drug for people with insomnia.
The agency approved the sale of Lunesta, made by the pharmaceutical company Sepracor, for both chronic and occasional insomnia, a problem for millions of people.
Lunesta was approved after clinical trials lasting more than a year showed it remained effective even when taker over time.
The drug, taken as a pill, is non-narcotic, the company reported, and helps people remain asleep all night, not just to fall asleep.
Written and revised by
David Cohen, M.D.
Our doctors write and review articles for accuracy and keep them up to date.
health.am provides general information, not medical advice. Always consult a qualified health professional about your own health.